Erika Hamilton MD, FASCO
@erikahamilton9.bsky.social
Director of Breast Cancer Research Program at Sarah Cannon Research Institute | Wife | Mom to 2 Girls | Tweets are My Own #Oncology #BCSM, #Cancer.
These are great short summaries!
June 4, 2025 at 4:12 PM
These are great short summaries!
It was for people who did not have progression on scan yet, but the emergence of a new mutation. So signaling progression was coming.
The sum of PFS and PFS2 will be important to see if people are benefiting from the two lines together longer than if the switch happened at PD.
The sum of PFS and PFS2 will be important to see if people are benefiting from the two lines together longer than if the switch happened at PD.
February 26, 2025 at 3:45 PM
It was for people who did not have progression on scan yet, but the emergence of a new mutation. So signaling progression was coming.
The sum of PFS and PFS2 will be important to see if people are benefiting from the two lines together longer than if the switch happened at PD.
The sum of PFS and PFS2 will be important to see if people are benefiting from the two lines together longer than if the switch happened at PD.
Ok, any experience using? What are the side effects or drug interactions?
February 24, 2025 at 6:07 AM
Ok, any experience using? What are the side effects or drug interactions?
Hmmmm, wonder if it's pretty insurance dependent. May try again at month two for her.
January 24, 2025 at 5:25 PM
Hmmmm, wonder if it's pretty insurance dependent. May try again at month two for her.